#Linkdoc ipo

[tonkitk]

Linkdoc ipo

Linkdoc ipo Offline#

Since April 2015, we have cumulatively cared for over 3.5 million patients and provided longitudinal care for over 2.5 million patients. We conduct personalized follow-up care through our call centers and online channels, and allow patients to consult physicians online via our Internet hospital and receive personalized disease management services. Working with healthcare providers and life sciences companies, we have conducted a large-scale multi-center retrospective study with a sample of 10,000 Chinese lung cancer patients, which demonstrated that our LinkCare Platform has improved patients’ survival rates meaningfully.

Linkdoc ipo Offline#

The platform integrates online and offline channels to help patients, especially those who suffer from cancer, better manage their illnesses as a chronic condition in and out of hospital. LinkCare Platform is a patient-centric digital continuous care platform for patients with critical diseases. We have successfully built China’s largest data-driven digital infrastructure for precision medicine, according to Frost & Sullivan, which consists of LinkCare, a digital continuous care platform for patients with critical diseases LinkData, an AI-enabled curation system for longitudinal medical data, and LinkSolutions, a data-driven precision life sciences solution platform that helps life sciences companies accelerate clinical research and real-world evidence adoption. We are a leading data-driven and AI-enabled healthcare technology company in terms of being a first mover in cultivating high-quality medical data assets with the largest set of China oncology cohorts, according to Frost & Sullivan.

[mainsslim]

Linkdoc ipo

The latest financing round was in March 2021. LinkDoc, as the first unicorn in the area of medical AI and big data, has finalized six rounds of financing backed by leading medical industry investors including Alibaba Health Information Technology Ltd (0241: HK), Temasek, and Lake Bleu Prime Healthcare Master Fund since its establishment in 2014. However, the loss widened in the first quarter of 2021 to CNY 80 million from 56 million in 2020. The corresponding net operating loss was CNY 138 million in 2021, an increase of 116% from CNY 64.15 million in 2020.įrom 2019 to 2020, the adjusted net loss narrowed to CNY 232 million from CNY 389 million. In the first quarter of 2021, the operating loss was CNY 90.216 million compared with CNY 59.08 million during the same period in 2020. The company, which is reportedly backed by Alibaba, filed for an IPO last month and was due to set a price for its shares later today (Thursday July 8). The corresponding net operating loss was CNY 434 million and CNY 488 million. LinkDoc Technology Ltd has suddenly shelved an IPO that was set to raise up to 211 million in the US, according to sources who spoke to Reuters and Nikkei. LinkDoc recorded an operating loss of CNY 408 million and CNY 250 million in 20 respectively. In the first quarter of 2021, they took a combined 80.2% of the total revenue, 6.8% lower than a year earlier About 75% and 85.5% of the total revenue in 20 was from them. The prospectus also showed that most of the earnings came from the sales of medicines and health care products. In the first quarter of 2021, LinkDoc generated CNY 223 million in revenue, compared to CNY 159 million in the same period in 2020. It is said that LinkDoc shelved the plan due to toughened Chinese cybersecurity regulations on overseas-listed companies.Īccording to its latest prospectus, LinkDoc’s revenue rose to CNY 941.6 million (USD 148 million) in 2020 from CNY 4.99 billion in 2019, up 89% year on year. However, it called off the process on July 9. On July 1, 2021, LinkDoc updated its IPO prospectus after it was first filed in June of the same year. LinkDoc Technology recently withdrew its IPO application in the US market after a nine-month halt to the process.

[journeylong]

Linkdoc ipo

So far this year, a record US$12.5 billion by Chinese firms has been raised from 34 US listings, Refinitiv data shows, well up from the US$1.9 billion from 14 deals in the same period a year ago.Įight Chinese companies including home service platform Daojia Ltd and Atour Lifestyle Holdings have made public filings with the Securities and Exchange Commission (SEC) to list in the US later this year, a review of the filings showed. A person familiar with the matter said such a plan is still under discussion and no decision has been made yet. US capital markets have been a lucrative source of funding for Chinese firms in the past decade, especially for technology companies looking to benchmark their valuations against listed peers there and tap an abundant liquidity pool. According to Bloomberg, LinkDoc Technology Limited, a medical data platform company backed by Alibaba Group, plans to lead a 200 to 300 million financing round before its upcoming IPO in Hong Kong. Morgan Stanley and Bank of America declined to comment, while CICC did not respond to a Reuters request for comment. Morgan Stanley, Bank of America, and China International Capital Corp Ltd (CICC) were the investment banks on the deal. LinkDoc did not immediately respond to a request for comment. The sources declined to be identified as the information has not yet been made public. An IPO is typically underwritten by one or more investment banks, who also arrange for the shares to be listed on one or more stock exchanges.Through this process, colloquially known as floating, or going. The book closed one day earlier than planned on Wednesday, one of the three sources and a separate person said. An initial public offering (IPO) or stock launch is a public offering in which shares of a company are sold to institutional investors and usually also to retail (individual) investors. It had planned to sell 10.8 million shares between US$17.50 and US$19.50 each.

[advisorslong]

Linkdoc ipo

The latest financing round was in March 2021. LinkDoc, as the first unicorn in the area of medical AI and big data, has finalized six rounds of financing backed by leading medical industry investors including Alibaba Health Information Technology Ltd (0241: HK), Temasek, and Lake Bleu Prime Healthcare Master Fund since its establishment in 2014. However, the loss widened in the first quarter of 2021 to CNY 80 million from 56 million in 2020. The corresponding net operating loss was CNY 138 million in 2021, an increase of 116% from CNY 64.15 million in 2020.įrom 2019 to 2020, the adjusted net loss narrowed to CNY 232 million from CNY 389 million. The company, which is reportedly backed by Alibaba, filed for an IPO last month and was due to set a price for its shares later today (Thursday July 8). In the first quarter of 2021, the operating loss was CNY 90.216 million compared with CNY 59.08 million during the same period in 2020. LinkDoc Technology Ltd has suddenly shelved an IPO that was set to raise up to 211 million in the US, according to sources who spoke to Reuters and Nikkei. The corresponding net operating loss was CNY 434 million and CNY 488 million. LinkDoc recorded an operating loss of CNY 408 million and CNY 250 million in 20 respectively. In the first quarter of 2021, they took a combined 80.2% of the total revenue, 6.8% lower than a year earlier About 75% and 85.5% of the total revenue in 20 was from them. The prospectus also showed that most of the earnings came from the sales of medicines and health care products. In the first quarter of 2021, LinkDoc generated CNY 223 million in revenue, compared to CNY 159 million in the same period in 2020. It is said that LinkDoc shelved the plan due to toughened Chinese cybersecurity regulations on overseas-listed companies.Īccording to its latest prospectus, LinkDoc’s revenue rose to CNY 941.6 million (USD 148 million) in 2020 from CNY 4.99 billion in 2019, up 89% year on year. However, it called off the process on July 9. On July 1, 2021, LinkDoc updated its IPO prospectus after it was first filed in June of the same year. LinkDoc Technology recently withdrew its IPO application in the US market after a nine-month halt to the process.

[funnygreys]

Linkdoc ipo

later this year, a review of the filings showed. listings, Refinitiv data shows, well up from the $1.9 billion from 14 deals in the same period a year ago.Įight Chinese companies including home service platform Daojia Ltd and Atour Lifestyle Holdings have made public filings with the Securities and Exchange Commission (SEC) to list in the U.S. So far this year, a record $12.5 billion by Chinese firms has been raised from 34 U.S. capital markets have been a lucrative source of funding for Chinese firms in the past decade, especially for technology companies looking to benchmark their valuations against listed peers there and tap an abundant liquidity pool. Morgan Stanley, Bank of America, and China International Capital Corp Ltd (CICC) were the investment banks on the deal and all declined to comment to Reuters. LinkDoc did not immediately respond to a request for comment. The sources declined to be identified as the information has not yet been made public. The book closed one day earlier than planned on Wednesday, one of the three sources and a separate person said. It had planned to sell 10.8 million shares between $17.50 and $19.50 each. and make it more difficult to raise funds overseas," he said.īacked by Alibaba Health Information Technology Ltd, LinkDoc filed for its IPO last month and was due to price its shares after the U.S. "The new rules may impose long waiting periods on any companies hoping to list abroad which will hit investor sentiment, depress valuations for IPOs in the U.S. listing, they may have to wait for further clarification, stricter scrutiny and pre-approval from different regulators and authorities," said Bruce Pang, macro & strategy research head at China Renaissance Securities. LinkDoc's decision to suspend its $211 million IPO, first reported by Reuters, is likely to be followed by others, analysts said, although they noted that U.S.

[hummingzone]

Exclusive: China's LinkDoc shelves $211 million US IPO after regulatory crackdown By Reuters

Exclusive: China’s LinkDoc shelves $211 million US IPO after regulatory crackdown By Reuters

© Reuters. By Scott Murdoch and Kane Wu HONG KONG (Reuters) – Chinese medical data group LinkDoc Technology Ltd has shelved its listing in the United States to raise up to $211 million following Beijing’s clampdown on overseas listings, according to three sources with direct knowledge of the matter. LinkDoc, which is described as a Chinese medical data solutions provider, filed for an initial…